ストックスクリーナーアプリを入手
6.52
1.36%
-0.09
アフターアワーズ：
6.52
前日終値:
$6.61
開ける：
$6.79
24時間の取引高:
2.47M
Relative Volume:
0.90
時価総額：
$556.92M
収益：
$161.10M
当期純損益:
$-308.60M
株価収益率:
-1.3961
EPS:
-4.67
ネットキャッシュフロー:
$-259.90M
1週間 パフォーマンス:
-14.55%
1か月 パフォーマンス:
-6.19%
6か月 パフォーマンス:
-75.22%
1年 パフォーマンス:
-79.26%
1日の値動き範囲:
$6.495
$7.05
1週間の範囲:
$6.495
$7.68
52週間の値動き範囲:
$5.935
$37.38
Arvinas Inc Stock (ARVN) Company Profile
ARVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARVN
Arvinas Inc
|
6.52 | 556.92M | 161.10M | -308.60M | -259.90M | -4.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
439.37 | 128.45B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.63 | 65.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
560.90 | 40.09B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.19 | 35.67B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
233.25 | 27.44B | 3.81B | -644.79M | -669.77M | -6.24 |
Arvinas Inc Stock (ARVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-05 | ダウングレード | Truist | Buy → Hold |
| 2025-05-02 | ダウングレード | Jefferies | Buy → Hold |
| 2025-05-02 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-03-13 | ダウングレード | Goldman | Buy → Neutral |
| 2025-03-12 | ダウングレード | Wedbush | Outperform → Neutral |
| 2025-03-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-12-10 | 開始されました | BTIG Research | Buy |
| 2024-11-18 | 開始されました | Stephens | Overweight |
| 2024-02-28 | 繰り返されました | Oppenheimer | Outperform |
| 2024-02-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-01 | 開始されました | Goldman | Buy |
| 2023-12-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-12-06 | アップグレード | Jefferies | Hold → Buy |
| 2023-11-20 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-10-23 | アップグレード | Wedbush | Neutral → Outperform |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2023-01-12 | ダウングレード | Guggenheim | Buy → Neutral |
| 2023-01-03 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-09-09 | 開始されました | Barclays | Overweight |
| 2022-06-21 | 開始されました | Jefferies | Hold |
| 2022-05-09 | ダウングレード | Wedbush | Outperform → Neutral |
| 2022-04-28 | 開始されました | Credit Suisse | Outperform |
| 2022-04-06 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-02-11 | 再開されました | BMO Capital Markets | Outperform |
| 2022-02-10 | 開始されました | Wells Fargo | Overweight |
| 2022-01-19 | 開始されました | Goldman | Buy |
| 2021-12-07 | 開始されました | Cowen | Outperform |
| 2021-10-14 | 開始されました | SVB Leerink | Outperform |
| 2021-09-30 | 開始されました | Stifel | Buy |
| 2021-09-09 | 開始されました | BofA Securities | Buy |
| 2021-05-21 | 開始されました | UBS | Buy |
| 2021-04-21 | 開始されました | Truist | Buy |
| 2021-03-31 | 開始されました | BMO Capital Markets | Outperform |
| 2020-12-14 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-06-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-05-12 | 開始されました | Oppenheimer | Perform |
| 2019-12-19 | 開始されました | H.C. Wainwright | Buy |
| 2019-11-25 | 開始されました | Guggenheim | Buy |
| 2019-10-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-09-25 | 開始されました | Wedbush | Outperform |
| 2019-09-12 | 開始されました | BMO Capital Markets | Outperform |
| 2019-08-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-05 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-04-12 | 開始されました | Evercore ISI | Outperform |
| 2018-10-22 | 開始されました | Citigroup | Buy |
| 2018-10-22 | 開始されました | Goldman | Neutral |
| 2018-10-22 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Arvinas Inc (ARVN) 最新ニュース
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, Inc.ARVN - PR Newswire
Did Arvinas, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateARVN - ACCESS Newswire
Algert Global LLC Acquires 37,927 Shares of Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
An Investigation Has Commenced on Behalf of Arvinas, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your ARVN Losses. - ACCESS Newswire
Dimensional Fund Advisors LP Grows Stake in Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Morgan Stanley Lowers Arvinas (NASDAQ:ARVN) Price Target to $11.00 - Defense World
Arvinas (NASDAQ:ARVN) Receives "Hold" Rating from Truist Financial - MarketBeat
BMO Capital Markets Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock Price - MarketBeat
(ARVN) Investment Analysis - news.stocktradersdaily.com
Citigroup Has Lowered Expectations for Arvinas (NASDAQ:ARVN) Stock Price - MarketBeat
Arvinas, Inc. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsARVN - ACCESS Newswire
Morgan Stanley Adjusts Price Target for Arvinas (ARVN) | ARVN Stock News - GuruFocus
Morgan Stanley Cuts Price Target on Arvinas to $11 From $12, Keeps Equalweight Rating - marketscreener.com
Dimensional Fund Advisors LP Raises Position in Arvinas, Inc. (NASDAQ:ARVN) - Defense World
Short Interest in Arvinas, Inc. (NASDAQ:ARVN) Expands By 21.0% - MarketBeat
FY2025 EPS Estimates for Arvinas Lifted by Cantor Fitzgerald - Defense World
ArrowMark Colorado Holdings LLC Buys 532,105 Shares of Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
Levi & Korsinsky Announces an Investigation on Behalf of Arvinas, Inc. (ARVN) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
ARVINAS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Boxer Capital Management LLC Purchases Shares of 1,058,614 Arvinas, Inc. (NASDAQ:ARVN) - MarketBeat
ARVN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Arvinas, Inc. - ACCESS Newswire
ARVN ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Arvinas, Inc. Shareholders Who Lost Money - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN) Investors to Inquire about Securities Investigation - ACCESS Newswire
Arvinas, Inc. (ARVN) Investors May Be Able to Recover Losses By Reaching Out To Block & Leviton Regarding Securities Fraud Investigation - TradingView
PROTAC Market to See Booming Growth 2025-2032 | Arvinas, Celgene, Nurix Therapeutics, Hinova Pharmaceuticals - openPR.com
Arvinas (NASDAQ:ARVN) Earns "Hold" Rating from Jefferies Financial Group - MarketBeat
HC Wainwright Issues Pessimistic Forecast for Arvinas (NASDAQ:ARVN) Stock Price - MarketBeat
Piper Sandler Reiterates Overweight Rating for Arvinas (NASDAQ:ARVN) - MarketBeat
Arvinas (NASDAQ:ARVN) and Mustang Bio (NASDAQ:MBIO) Financial Contrast - Defense World
Kirby McInerney LLP Announces Investigation of Claims Against FTI Consulting, Inc. (FCN) on Behalf of Investors - GlobeNewswire Inc.
Arvinas, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsARVN - ACCESS Newswire
Arvinas, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsARVN - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Arvinas, Inc. (ARVN) And Encourages Investors to Reach Out - ACCESS Newswire
Arvinas, Inc. (NASDAQ:ARVN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Arvinas targets regulatory filing for Vepdegestrant in metastatic breast cancer by 2025 - MSN
Arvinas (ARVN) Price Target Adjustment by Citigroup | ARVN Stock News - GuruFocus
Kirby McInerney LLP Announces Investigation of Potential Claims Against Arvinas, Inc. (ARVN) on Behalf of Investors - GlobeNewswire
Arvinas (NASDAQ:ARVN) Price Target Cut to $9.50 by Analysts at Citigroup - Defense World
Arvinas (NASDAQ:ARVN) Price Target Lowered to $10.00 at BMO Capital Markets - Defense World
Arvinas, Inc. (NASDAQ:ARVN) Shares Purchased by Schonfeld Strategic Advisors LLC - MarketBeat
Arvinas (ARVN) Sees Analyst Downgrade and Significant Price Targ - GuruFocus
ARVN: BMO Capital Maintains Rating While Lowering Price Target | - GuruFocus
Where Arvinas Stands With Analysts - Benzinga
Citi cuts Arvinas stock price target to $9.50, keeps neutral rating - Investing.com Nigeria
Citi cuts Arvinas stock price target to $9.50, keeps neutral rating By Investing.com - Investing.com South Africa
Arvinas (ARVN) Downgraded by Truist Amid Market Concerns | ARVN Stock News - GuruFocus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arvinas, ... - Bluefield Daily Telegraph
ARVN: BMO Capital Maintains Rating While Lowering Price Target | ARVN Stock News - GuruFocus
Arvinas (NASDAQ:ARVN) Releases Earnings Results - MarketBeat
Arvinas (ARVN) Target Price Lowered by Citi Amid Pipeline Develo - GuruFocus
Truist Downgrades Arvinas to Hold From Buy, Cuts Price Target to $11 From $21 - marketscreener.com
Arvinas Inc (ARVN) 財務データ
収益
当期純利益
現金流量
EPS
4.10%
大文字化:
|
ボリューム (24 時間):